Drug developer City Therapeutics files for US IPO
Tweet
Share
E-mail
FILE PHOTO: Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration/File Photo
Sept 24 (Reuters) - Drug developer City Therapeutics filed for an initial public offering in the US on Thursday.
The Cambridge, Massachusetts-based company plans to sell new shares in the IPO.
City Therapeutics will list on the Nasdaq under the symbol “CTY.”
Goldman Sachs, Jefferies, Stifel and Oppenheimer are the underwriters for the offering.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Jonathan Ananda)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elmet to buy 4.99% stake in Masan High-Tech Materials for $2.5B valuation
- Trump and Xi agreed to support each other in hosting APEC, G20 summits, Xinhua reports
- Finnish leader pleads with Musk to help Ukraine hit Russian missile launchers
Create E-mail Alert Related Categories
ReutersRelated Entities
Stifel, Goldman Sachs, Jefferies & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
